Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Fluvoxamine“
Suchtreffer
Begriffe & Kennungen
Olanzapine Glenmark · 4.5 · A lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other CY
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Teva · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Teva · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female nonsmokers and 77 % in male smok
Eintrag öffnenOlazax Disperzi · 4.5 · The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female nonsmokers and 77 % in male smok
Eintrag öffnenOlazax Disperzi · 4.5 · The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female nonsmokers and 77 % male smokers
Eintrag öffnenOlazax · 4.5 · A lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other CY
Eintrag öffnenOlazax · 4.5 · A lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other CY
Eintrag öffnenOlazax · 4.5 · A lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other CY
Eintrag öffnen